Universe Pharmaceuticals (UPC) Receivables Refunds (2023 - 2025)
Historic Receivables Refunds for Universe Pharmaceuticals (UPC) over the last 3 years, with Q3 2025 value amounting to $1.0 billion.
- Universe Pharmaceuticals' Receivables Refunds rose 11523.61% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 11523.61%. This contributed to the annual value of $1.0 billion for FY2025, which is 11523.61% up from last year.
- Universe Pharmaceuticals' Receivables Refunds amounted to $1.0 billion in Q3 2025, which was up 11523.61% from $475.3 million recorded in Q3 2024.
- In the past 5 years, Universe Pharmaceuticals' Receivables Refunds ranged from a high of $1.0 billion in Q3 2025 and a low of $478899.0 during Q3 2023
- Moreover, its 3-year median value for Receivables Refunds was $475.3 million (2024), whereas its average is $499.6 million.
- Per our database at Business Quant, Universe Pharmaceuticals' Receivables Refunds surged by 9915495.77% in 2024 and then surged by 11523.61% in 2025.
- Universe Pharmaceuticals' Receivables Refunds (Quarter) stood at $478899.0 in 2023, then soared by 99154.96% to $475.3 million in 2024, then soared by 115.24% to $1.0 billion in 2025.
- Its last three reported values are $1.0 billion in Q3 2025, $475.3 million for Q3 2024, and $478899.0 during Q3 2023.